1. Home
  2. XOMAP vs MAPSW Comparison

XOMAP vs MAPSW Comparison

Compare XOMAP & MAPSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMAP
  • MAPSW
  • Stock Information
  • Founded
  • XOMAP N/A
  • MAPSW N/A
  • Country
  • XOMAP United States
  • MAPSW United States
  • Employees
  • XOMAP 13
  • MAPSW 440
  • Industry
  • XOMAP Biotechnology: Pharmaceutical Preparations
  • MAPSW Computer Software: Prepackaged Software
  • Sector
  • XOMAP Health Care
  • MAPSW Technology
  • Exchange
  • XOMAP Nasdaq
  • MAPSW Nasdaq
  • Market Cap
  • XOMAP N/A
  • MAPSW N/A
  • IPO Year
  • XOMAP N/A
  • MAPSW 2019
  • Fundamental
  • Price
  • XOMAP $26.08
  • MAPSW $0.03
  • Analyst Decision
  • XOMAP
  • MAPSW
  • Analyst Count
  • XOMAP 0
  • MAPSW 0
  • Target Price
  • XOMAP N/A
  • MAPSW N/A
  • AVG Volume (30 Days)
  • XOMAP N/A
  • MAPSW N/A
  • Earning Date
  • XOMAP N/A
  • MAPSW N/A
  • Dividend Yield
  • XOMAP N/A
  • MAPSW N/A
  • EPS Growth
  • XOMAP N/A
  • MAPSW N/A
  • EPS
  • XOMAP N/A
  • MAPSW N/A
  • Revenue
  • XOMAP N/A
  • MAPSW N/A
  • Revenue This Year
  • XOMAP N/A
  • MAPSW N/A
  • Revenue Next Year
  • XOMAP N/A
  • MAPSW N/A
  • P/E Ratio
  • XOMAP N/A
  • MAPSW N/A
  • Revenue Growth
  • XOMAP N/A
  • MAPSW N/A
  • 52 Week Low
  • XOMAP N/A
  • MAPSW N/A
  • 52 Week High
  • XOMAP N/A
  • MAPSW N/A
  • Technical
  • Relative Strength Index (RSI)
  • XOMAP 52.06
  • MAPSW N/A
  • Support Level
  • XOMAP $25.72
  • MAPSW N/A
  • Resistance Level
  • XOMAP $26.00
  • MAPSW N/A
  • Average True Range (ATR)
  • XOMAP 0.18
  • MAPSW 0.00
  • MACD
  • XOMAP -0.03
  • MAPSW 0.00
  • Stochastic Oscillator
  • XOMAP 49.64
  • MAPSW 0.00

About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About MAPSW WM Technology Inc.

WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.

Share on Social Networks: